Latest Operation Pangea Prompts Asian Crackdowns
This article was originally published in PharmAsia News
Executive Summary
As part of the annual global Operation Pangea, coordinated by Interpol to crack down on counterfeit drugs and illicit online sales of medicines and medical devices, South Korea's Ministry of Food and Drug Safety has uncovered more than 800 websites that illegally sell medicines to consumers, while other Asian authorities are also taking action.
You may also be interested in...
Malaysia Steps Up Surveillance Of Counterfeit Drugs
SHANGHAI - The Malaysian Padang Besar Anti-Smuggling Unit seized 12,285 bottles of China-made herb capsules and Chinese medicine at the Malaysian-Thai border in early December, the authorities announced recently
Interpol Seizes Counterfeit Drugs In Southeast Asia; More Measures Mulled
The International Criminal Police Organization confiscated $6.65 million worth of counterfeit HIV/AIDS, malaria and tuberculosis drugs in Southeast Asia, the organization announced at the International Law Enforcement Training Seminar on Combating Counterfeit Drugs Nov. 17 in Phnom Penh, Cambodia
No Korea-Originated New Drugs Approved Domestically In 2023
Notable new drug approvals in South Korea last year included Pfizer’s Tukysa, Genentech’s Columvi and BeiGene’s Tevimbra, but the tally did not include any domestically-originated products. Alzheimer’s disease therapy lecanemab may be on the horizon this year.